Governance ResMed, Inc.

RMD

US7611521078

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 21:00:02 04/12/2025 GMT			5-day change	1st Jan Change
251.51 ^USD	+0.03%		-1.38%	+9.98%

12-04	Resmed Insider Sold Shares Worth $502,940, According to a Recent SEC Filing	MT
12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI

Executive Committee: ResMed, Inc.

Manager

Positions heldSince

Mick Farrell

52 year

Chief Executive Officer

28/02/2013

Sallilyn Schwartz

Investor Relations Contact

20/04/2025

Jim Ellis

Compliance Officer

31/12/2017

Yvonne-Katrin Pucknat

Sales & Marketing

08/11/2023

Michael Rider

General Counsel	30/06/2023
Corporate Secretary	30/06/2023

Brett Sandercock

58 year

Director of Finance/CFO

31/12/2005

Vered Keisar

Human Resources Officer

28/02/2021

Carlos Nunez

Chief Tech/Sci/R&D Officer

02/01/2017

Composition of the Board of Directors: ResMed, Inc.

Director

CommitteesSince

Mick Farrell

52 year

Compensation Committee Chair

11/12/2014

Karen Drexler

65 year

Audit Committee	07/11/2021
Compensation Committee Chair	07/11/2021
Governance Committee	16/11/2017
Nominating Committee	16/11/2017
Compensation Committee
Governance Committee Chair	07/01/2021
Nominating Committee Chair	07/11/2021

Peter Farrell

82 year

Audit Committee	30/05/2018
Executive Committee	30/05/2018
Compensation Committee	30/05/2018
Governance Committee Chair	30/05/2018
Nominating Committee Chair	30/05/2018

Carol Burt

67 year

Audit Committee	30/09/2019
Governance Committee	31/10/2013
Nominating Committee Chair	31/10/2013
Audit Committee Chair
Compensation Committee Chair

Ron Taylor

77 year

Audit Committee	31/12/2004
Governance Committee	12/03/2015
Nominating Committee	12/03/2015

Harjit Gill

60 year

Audit Committee	14/11/2018
Compensation Committee	14/11/2018

Nicole Mowad-Nassar

54 year

Compensation Committee

14/08/2025

Jan De Witte

60 year

Audit Committee

15/05/2019

John Hernandez

58 year

Audit Committee

Desney Tan

49 year

Compensation Committee

17/11/2021

Christopher DelOrefice

53 year

Audit Committee Chair

14/08/2024

Latest Appointments: ResMed, Inc.

12-02	LivaNova PLC Appoints Lucile Blaise as Global Head of Commercialization, Obstructive Sleep Apnea, Effective December 1, 2025	CI
11-25	ResMed Inc. Announces Not Seek Re-Election of Richard Sulpizio to the Board of Directors, Effective November 19, 2025	CI
10-15	NZX Announces Executive Changes	CI
10-14	PolyNovo Limited Announces Appointment of Robert Douglas to the Board of Directors	CI
08-18	Resmed announces election of Nicole Mowad-Nassar to board, upcoming retirement of Rich Sulpizio	RE
08-18	ResMed Inc. Announces Board Changes	CI
08-01	Resmed Inc. Announces Resignation of Bobby Ghoshal as Chief Commercial Officer, Residential Care Software Business, Effective August 1, 2025	CI

More news

Former Officers and Directors: ResMed, Inc.

Insider

Positions held

SinceUntil

Rich Sulpizio

Director/Board Member	24/08/2005	18/11/2025
Independent Dir/Board Member	24/08/2005	18/11/2025

Bobby Ghoshal

Chief Tech/Sci/R&D Officer	01/04/2018	31/01/2022
Corporate Officer/Principal	31/01/2022	31/07/2025

Rob Douglas

Chief Operating Officer	01/09/2011	08/11/2023
Corporate Officer/Principal	31/12/2001	01/09/2011
President	28/02/2013	08/11/2023
Sales & Marketing	31/12/2000	31/12/2001

Urvashi Tyagi

Chief Tech/Sci/R&D Officer

31/01/2022

08/11/2023

Jayme Rubenstein

Public Communications Contact

30/06/2023

David Pendarvis

Chief Administrative Officer	30/04/2011	29/06/2023
General Counsel	31/08/2002	29/06/2023
Corporate Secretary	31/01/2003	29/06/2023

Anne Crotteau

Public Communications Contact

31/12/2017

31/07/2022

Mehul Joshi

Corporate Officer/Principal

30/04/2011

30/06/2022

James Hollingshead

Corporate Officer/Principal

28/02/2010

04/05/2022

Rajwant Singh Sodhi

Chief Tech/Sci/R&D Officer	30/06/2017	01/04/2018
Corporate Officer/Principal	01/04/2018	31/08/2021

Jack Wareham

Director/Board Member	31/12/2004	20/11/2019
Independent Dir/Board Member	31/12/2004	20/11/2019

Geoff Neilson

Corporate Officer/Principal

27/06/2011

30/11/2018

Amy Wakeham

Investor Relations Contact	31/05/2018	-
Public Communications Contact	31/05/2018	31/10/2023

Gary Pace

Director/Board Member	31/12/1993	31/12/2017
Independent Dir/Board Member	31/12/1993	31/12/2017

Chris Roberts

Director/Board Member	31/12/1991	16/11/2017
President	31/12/1991	16/11/2017

Frank Lacagnina

Chief Tech/Sci/R&D Officer

31/08/2010

31/10/2017

Anne Reiser

Corporate Officer/Principal

31/12/2005

31/08/2017

Andrew Price

Corporate Officer/Principal

30/06/2017

Nupur Bhushan

Human Resources Officer

30/06/2017

Richie McHale

Human Resources Officer

31/10/2013

Michael Quinn Anthony

Director/Board Member

30/06/1992

31/10/2013

Stein Jacobsen

Corporate Officer/Principal

31/12/2008

30/03/2012

Karen Borg

Corporate Officer/Principal

31/12/2011

Michael Zill

Chief Tech/Sci/R&D Officer

31/05/2006

30/11/2011

Jean-Claude Kyrillos

President

31/12/2007

31/07/2011

Kieran Gallahue

Director/Board Member	31/12/2007	27/01/2011
Chief Executive Officer	31/12/2007	27/01/2011
Corporate Officer/Principal	31/12/2002	31/08/2004
President	31/08/2004	27/01/2011

Donagh McCarthy

Director/Board Member

31/10/1994

29/05/2008

Keith M. Serzen

Corporate Officer/Principal

31/08/2003

08/04/2008

Lasse Beijer

Corporate Officer/Principal

31/05/2007

Adrian M. Smith

Corporate Officer/Principal

31/01/1995

30/05/2007

Todd Pinkowski

Corporate Officer/Principal

31/12/1997

31/12/2006

Harold Picken

Corporate Officer/Principal

31/12/2005

Christopher A. Bartlett

Director/Board Member

30/09/2000

24/08/2005

Connie L. Garrett

Human Resources Officer

31/12/1998

31/12/2003

Kristie Burns

Public Communications Contact	31/01/2016	-
Sales & Marketing	30/11/2003	31/01/2016

Wai Keei Sum

Corporate Officer/Principal

31/12/2002

Paul Eisen

Corporate Officer/Principal

31/12/2001

Donald Darkin

Corporate Officer/Principal

27/09/2010

Steve Moore

Sales & Marketing

Alison Graves

Public Communications Contact

Stefan Elterich

Sales & Marketing

Theresa Lowry

Human Resources Officer

Louis Allen Simpsoni

Director/Board Member

30/04/2002

24/01/2005

Zabrina Doerck

Public Communications Contact

Agnes Lee

Investor Relations Contact	-	-
Public Communications Contact	-	-

Jon Brockman

Corporate Officer/Principal

Leo Toole

Director of Finance/CFO

Birgit Fibian

Sales & Marketing

Matthew Borer

Public Communications Contact

27/10/2009

Jonathan C. Wright

Sales & Marketing

Michael S. Hirshorn

Director/Board Member

Ronald F. Richard

Sales & Marketing

Nicholas J. Kuhn

Corporate Officer/Principal

Hillary Theakston

Public Communications Contact

Constance C. Bienfait

Investor Relations Contact	-	-
Public Communications Contact	-	-

Walter Flicker

Corporate Officer/Principal

Curt Kenyon

Director/Board Member

Klaus H. Shindhelm

Chief Operating Officer

Anthony Ujhazy

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	18
Female	9

Of which Executive Committee

Male	5
Female	3

Of which Directors

Male	7
Female	4

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows: - medical devices (51.8%); - masks (35.7%); - software as a service (12.5%): residential care management software solutions. At the end of June 2025, the group had 8 production sites located in the United States (3), Australia, China, Singapore, Malaysia and France. The United States accounts for 63.8% of net sales.

Employees

10,600

Sector

Advanced Medical Equipment & Technology

Calendar

01-21 - Q2 2026 Earnings Release (Projected)

More about the company